Data / Form D filings / Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc.: Form D filings
Kleo Pharmaceuticals, Inc., a pharmaceuticals company in New Haven, CT, filed 4 Form D notices with the SEC between 2017 and 2019. The latest, on January 15, 2019, reports $21.2 million sold of a $21.2 million offering to 19 investors.
Find out what Kleo Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 25 SCIENCE PARK, SUITE 2D, 150 MUNSON ST., New Haven, CT, 06511
- Phone
- (203) 691-6332
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2015
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1700389
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 15, 2019 | New notice | $21,206,378 | $21,206,378 | $0 | 19 | Nov 12, 2018 | sec.gov |
| May 29, 2018 | Amendment | Indefinite | $13,531,612 | Indefinite | 11 | Aug 29, 2016 | sec.gov |
| May 26, 2017 | Amendment | Indefinite | $11,000,000 | Indefinite | 9 | Aug 29, 2016 | sec.gov |
| May 23, 2017 | New notice | Indefinite | $19,403,470 | Indefinite | 23 | Feb 28, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Douglas Manion | Executive Officer, Director | |
| Charles G. Drake | Director | |
| Declan Doogan | Director | |
| Roy Prieb | Executive Officer, Director | |
| Alexander Goor | Director | |
| John W. Childs | Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Jan 14, 2019 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Kleo Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.